Cargando…
Control of HIV Infection In Vivo Using Gene Therapy with a Secreted Entry Inhibitor
HIV entry inhibitors are highly effective in controlling virus replication. We have developed a lentiviral vector that expresses a secreted entry inhibitor, soluble CD4 (sCD4), which binds to the HIV envelope glycoproteins and inactivates the virus. We have shown that sCD4 was secreted from gene-mod...
Autores principales: | Falkenhagen, Alexander, Singh, Jastaranpreet, Asad, Sabah, Leontyev, Danila, Read, Stanley, Zúñiga-Pflücker, Juan Carlos, Joshi, Sadhna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633861/ https://www.ncbi.nlm.nih.gov/pubmed/29246292 http://dx.doi.org/10.1016/j.omtn.2017.08.017 |
Ejemplares similares
-
Lentiviral expression system for the purification of secreted proteins from human cell cultures
por: Falkenhagen, Alexander, et al.
Publicado: (2016) -
Further Characterization of the Bifunctional HIV Entry Inhibitor sCD4-FI(T45)
por: Falkenhagen, Alexander, et al.
Publicado: (2017) -
HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins
por: Falkenhagen, Alexander, et al.
Publicado: (2018) -
Thymic Engraftment by in vitro-Derived Progenitor T Cells in Young and Aged Mice
por: Singh, Jastaranpreet, et al.
Publicado: (2020) -
Genetic Strategies for HIV Treatment and Prevention
por: Falkenhagen, Alexander, et al.
Publicado: (2018)